{"id":"NCT01555125","sponsor":"Novartis Pharmaceuticals","briefTitle":"First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks","officialTitle":"A Randomized, Double-blind, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Efficacy After Twelve Weeks of Treatment, and to Assess the Safety, Tolerability, Usability and Long-term Efficacy in Subjects With Chronic Plaque-type Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-08","primaryCompletion":"2016-10-24","completion":"2016-10-24","firstPosted":"2012-03-15","resultsPosted":"2018-08-08","lastUpdate":"2018-08-08"},"enrollment":177,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Moderate to Severe Plaque-type Psoriasis"],"interventions":[{"type":"DRUG","name":"secukinumab 150 mg","otherNames":[]},{"type":"DRUG","name":"secukinumab 300 mg","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"secukinumab 150 mg","type":"EXPERIMENTAL"},{"label":"secukinumab 300 mg","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate efficacy of secukinumab at Week 12 based on PASI and IGA response rates versus placebo in subjects with moderate to severe chronic plaque-type psoriasis.","primaryOutcome":{"measure":"Efficacy of Secukinumab Compared to Placebo in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis at Week 12 Measure: PASI 75 (Psoriasis Area and Severity Index) Response.","timeFrame":"12 weeks","effectByArm":[{"arm":"AIN457 150 mg","deltaMin":69.5,"sd":null},{"arm":"AIN457 300 mg","deltaMin":75.9,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":33,"countries":["United States","Canada","Estonia","France","Germany"]},"refs":{"pmids":["37341961","35305260","34110605","27576559","27573260"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":59},"commonTop":["NASOPHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION","DIARRHOEA","COUGH","ARTHRALGIA"]}}